Rockwell Medical Inc
NASDAQ:RMTI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.23
4.65
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one RMTI stock under the Base Case scenario is 1.83 USD. Compared to the current market price of 2.25 USD, Rockwell Medical Inc is Overvalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Rockwell Medical Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for RMTI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Rockwell Medical Inc
Balance Sheet Decomposition
Rockwell Medical Inc
Current Assets | 34.2m |
Cash & Short-Term Investments | 18.3m |
Receivables | 8.9m |
Other Current Assets | 7.1m |
Non-Current Assets | 22.9m |
PP&E | 10.9m |
Intangibles | 11.3m |
Other Non-Current Assets | 726k |
Current Liabilities | 14.2m |
Accounts Payable | 2.6m |
Accrued Liabilities | 7.8m |
Short-Term Debt | 469k |
Other Current Liabilities | 3.3m |
Non-Current Liabilities | 13.8m |
Long-Term Debt | 9.5m |
Other Non-Current Liabilities | 4.3m |
Earnings Waterfall
Rockwell Medical Inc
Revenue
|
98.9m
USD
|
Cost of Revenue
|
-82.2m
USD
|
Gross Profit
|
16.7m
USD
|
Operating Expenses
|
-16.1m
USD
|
Operating Income
|
580k
USD
|
Other Expenses
|
-1.8m
USD
|
Net Income
|
-1.2m
USD
|
Free Cash Flow Analysis
Rockwell Medical Inc
USD | |
Free Cash Flow | USD |
RMTI Profitability Score
Profitability Due Diligence
Rockwell Medical Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Rockwell Medical Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
RMTI Solvency Score
Solvency Due Diligence
Rockwell Medical Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Rockwell Medical Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RMTI Price Targets Summary
Rockwell Medical Inc
According to Wall Street analysts, the average 1-year price target for RMTI is 7.65 USD with a low forecast of 6.06 USD and a high forecast of 9.45 USD.
Dividends
Current shareholder yield for RMTI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
RMTI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.
Contact
IPO
Employees
Officers
The intrinsic value of one RMTI stock under the Base Case scenario is 1.83 USD.
Compared to the current market price of 2.25 USD, Rockwell Medical Inc is Overvalued by 19%.